Gabrielle Sulzberger's most recent trade in Mastercard Incorporated - Ordinary Shares - Class A was a trade of 458 Class A Common Stock done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mastercard | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 458 | 5,336 (0%) | 0% | 0 | Class A Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.50 per share. | 16 Jun 2025 | 6 | 2,579 (0%) | 0% | 826.5 | 4,959 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.33 per share. | 19 May 2025 | 6 | 2,568 (0%) | 0% | 826.3 | 4,958 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.33 per share. | 21 Apr 2025 | 6 | 2,562 (0%) | 0% | 826.3 | 4,958 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.33 per share. | 17 Mar 2025 | 6 | 2,556 (0%) | 0% | 826.3 | 4,958 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 991.60 per share. | 18 Feb 2025 | 5 | 2,545 (0%) | 0% | 991.6 | 4,958 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.33 per share. | 21 Jan 2025 | 6 | 2,539 (0%) | 0% | 826.3 | 4,958 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.42 per share. | 16 Dec 2024 | 12 | 2,532 (0%) | 0% | 826.4 | 9,917 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 2,516 (0%) | 0% | 728.5 | 220,000 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 762.85 per share. | 18 Nov 2024 | 13 | 2,214 (0%) | 0% | 762.8 | 9,917 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 906.09 per share. | 21 Oct 2024 | 11 | 2,201 (0%) | 0% | 906.1 | 9,967 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 923.55 per share. | 16 Sep 2024 | 11 | 2,190 (0%) | 0% | 923.5 | 10,159 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 921.82 per share. | 19 Aug 2024 | 11 | 2,176 (0%) | 0% | 921.8 | 10,140 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 950.50 per share. | 15 Jul 2024 | 10 | 2,165 (0%) | 0% | 950.5 | 9,505 | Common Stock |
| Mastercard | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 545 | 4,878 (0%) | 0% | 0 | Class A Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 885.00 per share. | 17 Jun 2024 | 11 | 2,155 (0%) | 0% | 885 | 9,735 | Common Stock |
| Warby Parker Inc - Ordinar... | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 14,793 | 84,024 | - | 0 | Class A Common Stock | |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,461 | 58,876 | - | - | Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 783.15 per share. | 20 May 2024 | 13 | 2,141 (0%) | 0% | 783.2 | 10,181 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 750.77 per share. | 15 Apr 2024 | 13 | 2,128 (0%) | 0% | 750.8 | 9,760 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 762.69 per share. | 18 Mar 2024 | 13 | 2,115 (0%) | 0% | 762.7 | 9,915 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 755.69 per share. | 20 Feb 2024 | 13 | 2,098 (0%) | 0% | 755.7 | 9,824 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 634.56 per share. | 16 Jan 2024 | 16 | 2,085 (0%) | 0% | 634.6 | 10,153 | Common Stock |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2023 | 562 | 48,415 | - | 0 | Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 579.78 per share. | 18 Dec 2023 | 9 | 2,069 (0%) | 0% | 579.8 | 5,218 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 2,057 (0%) | 0% | 597.6 | 200,196 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 597.62 per share. | 20 Nov 2023 | 8 | 1,722 (0%) | 0% | 597.6 | 4,781 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 616.62 per share. | 16 Oct 2023 | 8 | 1,714 (0%) | 0% | 616.6 | 4,933 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 571.33 per share. | 18 Sep 2023 | 9 | 1,706 (0%) | 0% | 571.3 | 5,142 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 550.56 per share. | 21 Aug 2023 | 9 | 1,694 (0%) | 0% | 550.6 | 4,955 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 447.18 per share. | 17 Jul 2023 | 11 | 1,685 (0%) | 0% | 447.2 | 4,919 | Common Stock |
| Mastercard | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 642 | 4,333 (0%) | 0% | 0 | Class A Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 451.91 per share. | 20 Jun 2023 | 11 | 1,674 (0%) | 0% | 451.9 | 4,971 | Common Stock |
| Warby Parker Inc - Ordinar... | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 23,116 | 69,231 | - | 0 | Class A Common Stock | |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,780 | 13,780 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,282 | 47,853 | - | - | Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 434.55 per share. | 15 May 2023 | 11 | 1,659 (0%) | 0% | 434.5 | 4,780 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 372.38 per share. | 17 Apr 2023 | 13 | 1,648 (0%) | 0% | 372.4 | 4,841 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 333.60 per share. | 20 Mar 2023 | 15 | 1,635 (0%) | 0% | 333.6 | 5,004 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 327.53 per share. | 21 Feb 2023 | 15 | 1,614 (0%) | 0% | 327.5 | 4,913 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 357.71 per share. | 17 Jan 2023 | 14 | 1,599 (0%) | 0% | 357.7 | 5,008 | Common Stock |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 49,624 | 14,270 | - | 0 | Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 357.79 per share. | 19 Dec 2022 | 28 | 1,585 (0%) | 0% | 357.8 | 10,018 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 1,554 (0%) | 0% | 361.2 | 179,863 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 361.19 per share. | 21 Nov 2022 | 27 | 1,056 (0%) | 0% | 361.2 | 9,752 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 332.77 per share. | 17 Oct 2022 | 30 | 1,029 (0%) | 0% | 332.8 | 9,983 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 305.09 per share. | 19 Sep 2022 | 33 | 999 (0%) | 0% | 305.1 | 10,068 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 313.94 per share. | 15 Aug 2022 | 32 | 963 (0%) | 0% | 313.9 | 10,046 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 321.77 per share. | 18 Jul 2022 | 31 | 931 (0%) | 0% | 321.8 | 9,975 | Common Stock |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 14,270 | 63,894 | - | - | Common Stock | |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 14,270 | 0 | - | - | Restricted Stock Units | |
| Mastercard | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 741 | 3,691 (0%) | 0% | 0 | Class A Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 297.33 per share. | 21 Jun 2022 | 33 | 900 (0%) | 0% | 297.3 | 9,812 | Common Stock |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,459 | 23,459 | - | - | Stock Option (Right to Buy) | |
| Warby Parker Inc - Ordinar... | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 16,559 | 46,115 | - | 0 | Class A Common Stock | |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 299.39 per share. | 16 May 2022 | 33 | 864 (0%) | 0% | 299.4 | 9,880 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 298.82 per share. | 18 Apr 2022 | 33 | 831 (0%) | 0% | 298.8 | 9,861 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 289.65 per share. | 21 Mar 2022 | 34 | 798 (0%) | 0% | 289.6 | 9,848 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 239.12 per share. | 22 Feb 2022 | 41 | 761 (0%) | 0% | 239.1 | 9,804 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 247.08 per share. | 18 Jan 2022 | 40 | 720 (0%) | 0% | 247.1 | 9,883 | Common Stock |
| Eli Lilly | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 258.43 per share. | 15 Nov 2021 | 677 | 677 (0%) | 0% | 258.4 | 174,957 | Common Stock |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 14,270 | 14,270 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 14,270 | 49,624 | - | - | Common Stock | |
| Mastercard | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 622 | 2,950 (0%) | 0% | 0 | Class A Common Stock | |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Purchase of securities on an exchange or from another person at price $ 13.06 per share. | 17 Jun 2021 | 21,084 | 35,354 | - | 13.1 | 275,357 | Common Stock |
| Cerevel Therapeutics Holdi... | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 58,003 | 58,003 | - | - | Stock Option (Right to Buy) | |
| Brixmor Property Group Inc | Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 5,000 | 37,161 (0%) | 0% | 0 | Common Stock |